IRMD
IRadimed Corporation
NASDAQ · Healthcare · Medical - Devices · US
$83.45
−3.63%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
35.4x
EV/EBITDA
32.4x
Market Cap
$1.07B
MomentumView details →
1D Return
−3.63%
YTD Return
−13.45%
RSI (14)
31.1
ValuationView details →
P/E (Fwd)
35.4x
EV/EBITDA
32.4x
Market Cap
$1.07B
RSI (14)
31.1
MomentumView details →
1D Return
−3.63%
YTD Return
−13.45%
SummaryUpdated Jun 1, 2026
IRadimed Corporation (NYSE:IRMD) is a specialized medical device manufacturer founded in 1992 and headquartered in Winter Springs, Florida. The company went public in July 2014 and has established itself as a leading provider of magnetic resonance imaging (MRI) compatible medical devices. IRadimed operates in the niche but critical market of developing equipment that can safely function within the powerful magnetic fields of MRI machines, serving hospitals, acute care facilities, and outpatient imaging centers across the United States and internationally.
Similar companies
Latest newsMore news →
iRadimed began general-release production of its new 3870 MRI IV pump system in the second quarter of 2026.35d agoIRADIMED CORPORATION reported second quarter 2026 revenue of $20.5 million, up 0.5% year-over-year, with GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46.35d agoIRADIMED CORPORATION announced a regular quarterly cash dividend of $0.20 per share.35d ago